The Relationship Between Gastric Xanthoma, Gastric Precancerous Lesions, and Gastric Cancer: A Retrospective Study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37417403/
Gastric xanthoma is closely related with gastric cancer and precancerous lesions.
Conclusions: Gastric xanthoma is closely related with gastric cancer and precancerous lesions.
Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis
Source : https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288111
Objective The association between blood lipid levels and the risk of gastric cancer (GC) is well known. Therefore, to clarify this association, all relevant prospective cohort studies were included in...
Conclusions: Based on the results of this meta-analysis, it was found that serum TC and HDL-C levels were inversely correlated with the risk of GC. No association was observed between serum TG levels and the risk of GC. Similarly, no association was found between serum LDL-C levels and the risk of GC.
Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy
Herein, we present a case of collagenous colitis in a patient who underwent chemotherapy for gastric cancer, comprising five cycles of S-1 plus oxaliplatin and trastuzumab, followed by five cycles...
Conclusions/Relevance: This case highlights the importance of considering collagenous colitis as a differential diagnosis, in addition to chemotherapy-induced colitis and immune-related adverse event (irAE) colitis, in patients with similar clinical presentations.
Fucoxanthin inhibits gastric cancer lymphangiogenesis and metastasis by regulating Ran expression
Source : https://www.sciencedirect.com/science/article/abs/pii/S0944711323002878?via=ihub
Lymph node metastasis is a key mechanism in gastric cancer (GC) metastasis and lymphangiogenesis is a vital step in the process of lymph node metastas...
Conclusions: Fucoxanthin suppressed GC-induced lymphangiogenesis and metastasis in vitro and in vivo by regulating Ran expression via the importinβ/NF-κB/VEGF-C nuclear transport signaling pathway. These novel findings provide the basis for the research and development of novel treatments using traditional Chinese medicine in treatment of...
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37364218/
Trastuzumab combined with ramucirumab and paclitaxel showed appreciable efficacy with manageable safety profiles in patients with previously treated HER2-positive G/GEJ cancer.
Conclusion: Trastuzumab combined with ramucirumab and paclitaxel showed appreciable efficacy with manageable safety profiles in patients with previously treated HER2-positive G/GEJ cancer.